Pharmacological cardioversion with Refralon

DRUG2 trials

Sponsors

National Medical Research Center for Cardiology, Ministry of Health of Russian Federation

Conditions

Atrial Fibrillation ParoxysmalAtrium; FibrillationAtrium; Flutter

Phase 4

Refralon Versus Amiodarone for Cardioversion of Paroxysmal Fibrillation and Atrial Flutter

CompletedNCT05445297

National Medical Research Center for Cardiology, Ministry of Health of Russian FederationAtrial Fibrillation Paroxysmal

Start: 2022-01-26End: 2023-06-30Updated: 2025-03-27

Unknown Phase

Refralon in Patients With Recurrence Paroxysmal and Persistent Forms of Atrial Fibrillation Who Underwent Catheter Ablation

CompletedNCT05456204

National Medical Research Center for Cardiology, Ministry of Health of Russian FederationAtrium; Fibrillation, Atrium; Flutter

Start: 2022-02-15End: 2024-06-30Updated: 2025-03-27